MODE OF ACTION, AND INVITRO AND INVIVO ACTIVITIES OF THE FLUOROQUINOLONES

[81] INVITRO COMPARISON OF A-56619, A-56620, AMIFLOXACIN, CIPROFLOXACIN, ENOXACIN, NORFLOXACIN, AND OFLOXACIN AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (02) : 325 - 326

[82] ACTIVITY OF CIPROFLOXACIN AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (05) : 688 - 691

[83] INVITRO EVALUATION OF A-56619 (DIFLOXACIN) AND A-56620 - NEW ARYL-FLUOROQUINOLONES [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (02) : 193 - 200

[84] COMPARISON OF CIPROFLOXACIN WITH AZLOCILLIN PLUS TOBRAMYCIN IN THE THERAPY OF EXPERIMENTAL PSEUDOMONAS-AERUGINOSA ENDOCARDITIS [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (03) : 428 - 432

[85] PEFLOXACIN THERAPY FOR EXPERIMENTAL ENDOCARDITIS CAUSED BY METHICILLIN-SUSCEPTIBLE OR METHICILLIN-RESISTANT STRAINS OF STAPHYLOCOCCUS-AUREUS [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (05) : 685 - 687

[86] SUSCEPTIBILITY OF CAMPYLOBACTER SPECIES TO NALIDIXIC-ACID, ENOXACIN, AND OTHER DNA GYRASE INHIBITORS [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (05) : 708 - 710

[87] INTRAPHAGOCYTIC BACTERICIDAL ACTIVITY OF BACTERIAL-DNA GYRASE INHIBITORS AGAINST SERRATIA-MARCESCENS [J]. CHEMOTHERAPY, 1984, 30 (06) : 379 - 386

[88] INCOMPLETE CROSS-RESISTANCE OF NALIDIXIC AND PIPEMIDIC ACID-RESISTANT VARIANTS OF SERRATIA-MARCESCENS AGAINST CIPROFLOXACIN, ENOXACIN, AND NORFLOXACIN [J]. CHEMOTHERAPY, 1985, 31 (01) : 34 - 39

[89] TSUKAMURA M, 1985, AM REV RESPIR DIS, V131, P348

[90] INTERACTION OF GENTAMICIN, DIBEKACIN, NETILMICIN AND AMIKACIN WITH VARIOUS PENICILLINS, CEPHALOSPORINS, MINOCYCLINE AND NEW FLUORO-QUINOLONES AGAINST ENTEROBACTERIACEAE AND PSEUDOMONAS-AERUGINOSA [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 16 (05) : 581 - 587

[81] INVITRO COMPARISON OF A-56619, A-56620, AMIFLOXACIN, CIPROFLOXACIN, ENOXACIN, NORFLOXACIN, AND OFLOXACIN AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (02) : 325 - 326

[82] ACTIVITY OF CIPROFLOXACIN AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (05) : 688 - 691

[83] INVITRO EVALUATION OF A-56619 (DIFLOXACIN) AND A-56620 - NEW ARYL-FLUOROQUINOLONES [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (02) : 193 - 200

[84] COMPARISON OF CIPROFLOXACIN WITH AZLOCILLIN PLUS TOBRAMYCIN IN THE THERAPY OF EXPERIMENTAL PSEUDOMONAS-AERUGINOSA ENDOCARDITIS [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (03) : 428 - 432

[85] PEFLOXACIN THERAPY FOR EXPERIMENTAL ENDOCARDITIS CAUSED BY METHICILLIN-SUSCEPTIBLE OR METHICILLIN-RESISTANT STRAINS OF STAPHYLOCOCCUS-AUREUS [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (05) : 685 - 687

[86] SUSCEPTIBILITY OF CAMPYLOBACTER SPECIES TO NALIDIXIC-ACID, ENOXACIN, AND OTHER DNA GYRASE INHIBITORS [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (05) : 708 - 710

[87] INTRAPHAGOCYTIC BACTERICIDAL ACTIVITY OF BACTERIAL-DNA GYRASE INHIBITORS AGAINST SERRATIA-MARCESCENS [J]. CHEMOTHERAPY, 1984, 30 (06) : 379 - 386

[88] INCOMPLETE CROSS-RESISTANCE OF NALIDIXIC AND PIPEMIDIC ACID-RESISTANT VARIANTS OF SERRATIA-MARCESCENS AGAINST CIPROFLOXACIN, ENOXACIN, AND NORFLOXACIN [J]. CHEMOTHERAPY, 1985, 31 (01) : 34 - 39

[89] TSUKAMURA M, 1985, AM REV RESPIR DIS, V131, P348

[90] INTERACTION OF GENTAMICIN, DIBEKACIN, NETILMICIN AND AMIKACIN WITH VARIOUS PENICILLINS, CEPHALOSPORINS, MINOCYCLINE AND NEW FLUORO-QUINOLONES AGAINST ENTEROBACTERIACEAE AND PSEUDOMONAS-AERUGINOSA [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 16 (05) : 581 - 587